Role of minimally invasive surgery in the management of localized pancreatic ductal adenocarcinoma: a review.

Autor: Kakati RT; Department of Surgical Oncology, University of North Carolina, Chapel Hill, NC, USA., Naffouje S; Department of Surgical Oncology, Cleveland Clinic Foundation, Cleveland, OH, USA., Spanheimer PM; Department of Surgical Oncology, University of North Carolina, Chapel Hill, NC, USA., Dahdaleh FS; Department of Surgical Oncology, Edward-Elmhurst Health, 120 Spalding Drive, Ste 205, Naperville, IL, 60540, USA. Fadi.Dahdaleh@EEHealth.org.
Jazyk: angličtina
Zdroj: Journal of robotic surgery [J Robot Surg] 2024 Feb 22; Vol. 18 (1), pp. 85. Date of Electronic Publication: 2024 Feb 22.
DOI: 10.1007/s11701-024-01825-w
Abstrakt: Pancreatic ductal adenocarcinoma (PDAC) remains a highly lethal malignancy with a minority of patients eligible for curative-intent surgical intervention. Pancreatic resections are technically demanding operations associated with considerable morbidity and mortality. Minimally invasive pancreatic resections (MIPRs), which include laparoscopic and robotic approaches, may enhance postoperative outcomes by lessening physiological impact of open surgery. A limited number of randomized-controlled trials as well as numerous retrospective reports have focused on MIPR outcomes and role in management of a variety of tumors, including PDAC. Today, MIPRs are generally considered acceptable alternatives to open surgery as a trend towards improved short-term metrics is observed. However, several questions remain regarding the oncological adequacy of MIPR's as long-term experience is less extensive compared to open techniques. This review aims to summarize existing evidence on MIPRs with a focus on PDAC.
(© 2024. The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature.)
Databáze: MEDLINE
Externí odkaz: